222 related articles for article (PubMed ID: 16996699)
1. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.
Tsai SJ
Med Hypotheses; 2007; 68(5):1144-6. PubMed ID: 16996699
[TBL] [Abstract][Full Text] [Related]
2. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain.
Dolotov OV; Karpenko EA; Seredenina TS; Inozemtseva LS; Levitskaya NG; Zolotarev YA; Kamensky AA; Grivennikov IA; Engele J; Myasoedov NF
J Neurochem; 2006 Apr; 97 Suppl 1():82-6. PubMed ID: 16635254
[TBL] [Abstract][Full Text] [Related]
3. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
4. Lithium and antidepressants: potential agents for the treatment of Rett syndrome.
Tsai SJ
Med Hypotheses; 2006; 67(3):626-9. PubMed ID: 16584849
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications.
Tsai SJ
Med Hypotheses; 2007; 68(4):896-9. PubMed ID: 16919891
[TBL] [Abstract][Full Text] [Related]
6. Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
Ben-Zeev B; Aharoni R; Nissenkorn A; Arnon R
Med Hypotheses; 2011 Feb; 76(2):190-3. PubMed ID: 20951500
[TBL] [Abstract][Full Text] [Related]
7. [Rett syndrome in a child treated with adrenocorticotrophic hormone].
Chen W; Liao JX; Chen L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):235-6. PubMed ID: 19292970
[No Abstract] [Full Text] [Related]
8. [Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat hippocampus and frontal cortex].
Agapova TIu; Agniullin IaV; Silachev DN; Shadrina MI; Slominskiĭ PA; Shram SI; Limborskaia SA; Miasoedov NF
Mol Gen Mikrobiol Virusol; 2008; (3):28-32. PubMed ID: 18756821
[TBL] [Abstract][Full Text] [Related]
9. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
[TBL] [Abstract][Full Text] [Related]
10. Rett syndrome: from the gene to the disease.
Matijevic T; Knezevic J; Slavica M; Pavelic J
Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
[TBL] [Abstract][Full Text] [Related]
11. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders.
Wong VC; Li SY
J Child Neurol; 2007 Dec; 22(12):1397-400. PubMed ID: 18174559
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized.
Bienvenu T; Chelly J
Nat Rev Genet; 2006 Jun; 7(6):415-26. PubMed ID: 16708070
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the MECP2 gene are not a major cause of Rett syndrome-like or related neurodevelopmental phenotype in male patients.
Santos M; Temudo T; Kay T; Carrilho I; Medeira A; Cabral H; Gomes R; Lourenço MT; Venâncio M; Calado E; Moreira A; Oliveira G; Maciel P
J Child Neurol; 2009 Jan; 24(1):49-55. PubMed ID: 19168818
[TBL] [Abstract][Full Text] [Related]
14. [Rett syndrome: clinical and molecular aspects].
Záhoráková D; Zeman J; Martásek P
Cas Lek Cesk; 2007; 146(8):647-52. PubMed ID: 17874730
[TBL] [Abstract][Full Text] [Related]
15. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
16. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
17. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome.
Nectoux J; Bahi-Buisson N; Guellec I; Coste J; De Roux N; Rosas H; Tardieu M; Chelly J; Bienvenu T
Neurology; 2008 May; 70(22 Pt 2):2145-51. PubMed ID: 18434641
[TBL] [Abstract][Full Text] [Related]
18. MECP2 mutations in Serbian Rett syndrome patients.
Djarmati A; Dobricić V; Kecmanović M; Marsh P; Jancić-Stefanović J; Klein C; Djurić M; Romac S
Acta Neurol Scand; 2007 Dec; 116(6):413-9. PubMed ID: 17986102
[TBL] [Abstract][Full Text] [Related]
19. Collicular dysfunction in attention deficit hyperactivity disorder.
Overton PG
Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).
Shim SH; Hwangbo Y; Kwon YJ; Jeong HY; Lee BH; Lee HJ; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1824-8. PubMed ID: 18760321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]